March 10, 2005

For Immediate Release

Spine Surgery Technologies, Products Generating Clinical Success, Driving and Sustaining Large Markets, According to New Report by MedMarket Diligence.

FOOTHILL RANCH, CA— The worldwide market for products in spine surgery is poised for strong and sustainable growth through the coming decades as a range of new products, from artificial discs to use of minimally invasive techniques and a wealth of osteobiologics find their way into a growing medical practice comprised of an active baby boomer population. The worldwide markets for these technologies, and the opportunities emerging, are detailed in a newly published report by MedMarket Diligence.  Analysis of the competitive landscape in spine surgery is also covered in the March issue of MedMarkets.

"The spine surgery marketplace is an arena for robust growth and market development of medical technologies," says Patrick Driscoll, President of MedMarket Diligence. "Since there is a large patient pool, numerous therapeutic alternatives possible for ameliorating spine-related problems and the advent of a very diverse range of technologies from image guidance, artificial discs, osteobiologics and others, the market will see sustainable revenue growth for well into the next few decades."

The MedMarket Diligence report on spine surgery is a worldwide medical market and technology assessment of the products, technologies, and companies in the market for spine surgical technologies for the treatment of congenital spine disorders, inflammatory and infectious diseases of the spine, degenerative spine diseases, mechancial disorders of the spine (herniation, stenosis, myelopathy, etc.), spinal trauma and tumors of the spine. Technologies addressed include the range of traditional "open" surgical procedures (fusion, corpectomy, foraminotomy, laminectomy, etc.) and minimally invasive procedures (vertebroplasty/kyphoplasty, microscoopic discectomy, disc decompression, endoscopic scoliosis surgery, minimally invasive bone grafting, etc.), as well as the full range of other device and osteobiologic technologies being applied or developed.

Companies involved in the market or pursuing technologies include: Aastrom Biosciences, AlloSource, Alphatec Manufacturing, Alphatec Manufacturing, Altiva Corporation, Arthrocare Corporation, Arthrocare/Parallax Medical, A-Spine USA,Inc., B. Braun Aesculap, Biocomposites, Biomet/Interpore Cross, Blackstone Medical, Cambridge Scientific, Cardinal Health, Cell-Based Bone Graft Substitutes, Cloward Instrument Corporation, Co-Ligne AG, Cook, Corin Group, Cortek, DePuy Spine, Disc-O-Tech Medical Technologies, Ltd., EBI, L.P., Encore Medical Corporation, Endius, Endospine Kinetics Limited, ETEX Corporation, HydroCision, Integra LifeSciences, Interpore Cross International, IsoTis OrthoBiologics, Jupiter Surgical Systems, Kyphon Inc., LifeNet, MacroPore Biosurgery Inc., Medtronic Sofamor Danek, MTF (Musculoskeletal Transplant Foundation), NeuColl, NuVasive, Orquest, Ortho Development Corporation, Orthovita, Osiris Therapeutics, OsteoBiologics, Osteoimplant Technology, Osteotech, Scient’X, SeaSpine, Smith & Nephew, Spinal Concepts, Spine Vision Inc., Spineology Inc., Stryker Biotech, Stryker Biotech, Stryker Spine, Synthes-Stratec, Therics, Trimedyne, Tutogen Medical, Valleylab, Verigen, Vertebron Inc., Wright Medical Technology and others.

Details of the report are available at

MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the MedMarkets newsletter, a monthly analysis of the market implications of new medical technology and dedicated reports on technology markets.  For additional details, contact Patrick Driscoll at email or call 949-859-3401 or toll-free (in the U.S.). 1-866-820-1357.